Page last updated: 2024-10-30

labetalol and Dyspnea

labetalol has been researched along with Dyspnea in 2 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Dyspnea: Difficult or labored breathing.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Odunukan, OW1
Abudiab, MM1
Sinak, LJ1
Zilcher, H1
Weber, H1
Glogar, D1

Other Studies

2 other studies available for labetalol and Dyspnea

ArticleYear
48-year-old man with cough and leg swelling.
    Mayo Clinic proceedings, 2012, Volume: 87, Issue:12

    Topics: Acute Disease; Antihypertensive Agents; Cerebrovascular Circulation; Cough; Dyspnea; Echocardiograph

2012
[Labetalol in ambulatory therapy of hypertension].
    Wiener medizinische Wochenschrift. Supplement, 1981, Volume: 69

    Topics: Adult; Aged; Ambulatory Care; Diabetes Mellitus, Type 1; Drug Evaluation; Dyspnea; Ethanolamines; Fe

1981